Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1<sup>*</sup>0401 MHC Class II Molecule.

HILL J A; SOUTHWOOD S; SETTE A; JEVNIKAR A M; BELL D A; CAIRNS E

Art

J-GLOBAL ID：200902221234194745 Reference number：03A0531149

Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1^*0401 MHC Class II Molecule.

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=03A0531149&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=03A0531149&from=J-GLOBAL&jstjournalNo=H0775A") }}

Author (6)： , , , , ,
Material：
Volume： 171 Issue： 2 Page： 538-541 Publication year： Jul. 15, 2003
JST Material Number： H0775A ISSN： 0022-1767 CODEN： JOIMA3 Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

Return to Previous Page

Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1*0401 MHC Class II Molecule.

Cutting Edge: The Conversion of Arginine to Citrulline Allows for a High-Affinity Peptide Interaction with the Rheumatoid Arthritis-Associated HLA-DRB1^*0401 MHC Class II Molecule.